Interview: Spain's Sanifit Set For Significant 2020
Calciphylaxis Drug In Phase III
The Mallorca-based biotech is building a strong data package for SNF472 which the company believes will be an effective treatment for a number of calcification disorders in dialysis patients.
You may also be interested in...
The agreement will give all EU member states the option to access the drug major's investigational COVID-19 vaccine dubbed AZD1222 "in an equitable manner at no profit during the pandemic."
With the Janssen and Novavax deals, the UK has now secured access to six different candidates across four different vaccine types.
The head of the German group's pharma BD team tells Scrip that Bayer has created a system which allows it to move quickly when sealing partnerships, as seen with the KaNDy buy on 11 August.